Quantcast

Latest Immunoglobulin E Stories

2011-05-06 15:13:07

Patients with severe allergic asthma that is inadequately controlled with the standard of care had improved symptoms and decreased flare-ups with injections of an antibody drug called omalizumab.

2011-05-06 06:30:00

SOUTH SAN FRANCISCO, Calif., May 6, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the company will assume development of R343, its inhaled syk inhibitor for allergic asthma that recently completed several Phase 1 clinical trials. Pfizer Inc.

2011-03-30 08:35:00

IRVINGTON, N.Y., March 30, 2011 /PRNewswire/ -- Itchy, runny nose, sneezing, watery eyes and itchy throat - we all know the symptoms that can make our children miserable from allergies.

2011-03-28 08:18:48

A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial sponsored by the National Institutes of Health has found.

2011-03-22 12:37:50

Some 3 million children in the United States have some form of food allergy, ranging in severity from mild to life-threatening.

2011-03-17 12:38:55

Stephen J. Teach, MD, MPH, Medical Director and Principal Investigator of IMPACT DC, a program of pediatric asthma care and research at Children's National Medical Center, served as the Site Principal Investigator for a new study that may advance asthma treatment and outcomes, specifically for inner-city children and teens.

2011-03-17 12:30:40

Researchers from Boston University School of Medicine (BUSM), in collaboration with researchers from the Inner City Asthma Consortium, have found that among inner-city children, the drug omalizumab improved asthma control, nearly eliminated seasonal exacerbations and reduced the need for controller medication.

2011-03-17 12:25:01

A drug that targets the antibody immunoglobulin E (IgE), a key player in asthma, nearly eliminated seasonal increases in asthma attacks and decreased asthma symptoms among young people living in inner city environments, a clinical trial sponsored by the National Institutes of Health has found.

2011-03-11 00:00:27

Cobalis Corp.'s PreHistin® Allergy Defense Formula, the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3.

2011-03-10 14:54:00

IRVINE, Calif., March 10, 2011 /PRNewswire/ -- Cobalis Corp.'s (Pink Sheets: CLSC) http://www.prehistin.com/ [PreHistin® Allergy Defense Formula], the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3.


Word of the Day
onomatope
  • An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.
Related